Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Aguiar

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2015
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and ParagangliomasRodrigo A Toledo, Yuejuan Qin, Zi-Ming Cheng, et al.
Nature Genetics|February 16, 2010
Germline mutations in TMEM127 confer susceptibility to pheochromocytomaYuejuan Qin, Li Yao, Elizabeth E King, et al.
Blood|April 2, 2014
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinibChan Y Cheah, Kate Burbury, Jane F Apperley, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2019
Synonymous but Not Silent: A Synonymous VHL Variant in Exon 2 Confers Susceptibility to Familial Pheochromocytoma and von Hippel-Lindau DiseaseShahida K Flores, Ziming Cheng, Angela M Jasper, et al.
Nature Communications|July 17, 2015
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2An-Ping Lin, Saman Abbas, Sang-Woo Kim, et al.
Blood|November 20, 2004
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory responseStefano Monti, Kerry J Savage, Jeffery L Kutok, et al.
Nature Medicine|January 12, 2002
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learningMargaret A Shipp, Ken N Ross, Pablo Tamayo, et al.
Cell Reports|September 2, 2023
TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradationQianjin Guo, Zi-Ming Cheng, Hector Gonzalez-Cantú, et al.
Nature Communications|October 19, 2019
The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific mannerSubramanya Srikantan, Yilun Deng, Zi-Ming Cheng, et al.
Blood|August 23, 2003
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphomaKerry J Savage, Stefano Monti, Jeffery L Kutok, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2015
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and ParagangliomasRodrigo A Toledo, Yuejuan Qin, Zi-Ming Cheng, et al.
Nature Genetics|February 16, 2010
Germline mutations in TMEM127 confer susceptibility to pheochromocytomaYuejuan Qin, Li Yao, Elizabeth E King, et al.
Blood|April 2, 2014
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinibChan Y Cheah, Kate Burbury, Jane F Apperley, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2019
Synonymous but Not Silent: A Synonymous VHL Variant in Exon 2 Confers Susceptibility to Familial Pheochromocytoma and von Hippel-Lindau DiseaseShahida K Flores, Ziming Cheng, Angela M Jasper, et al.
Nature Communications|July 17, 2015
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2An-Ping Lin, Saman Abbas, Sang-Woo Kim, et al.
Blood|November 20, 2004
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory responseStefano Monti, Kerry J Savage, Jeffery L Kutok, et al.
Nature Medicine|January 12, 2002
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learningMargaret A Shipp, Ken N Ross, Pablo Tamayo, et al.
Cell Reports|September 2, 2023
TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradationQianjin Guo, Zi-Ming Cheng, Hector Gonzalez-Cantú, et al.
Nature Communications|October 19, 2019
The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific mannerSubramanya Srikantan, Yilun Deng, Zi-Ming Cheng, et al.
Blood|August 23, 2003
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphomaKerry J Savage, Stefano Monti, Jeffery L Kutok, et al.
Pageof 9